BioRestorative Therapies BRTX
NASDAQ BRTX
$2.20 -0.07 (-3.08%)
At close: Oct 2, 2026 · 4:00 PM EDT

BioRestorative Therapies (BRTX) Return on Sales [ROS] (2012 - 2025)

Updated

BioRestorative Therapies (BRTX) reported Return on Sales [ROS] of -19516.84% for Q4 2025, down 13304.04 percentage points from -6212.80% a year earlier but up 11915.46 percentage points from the prior quarter.

Analysis

BioRestorative Therapies (BRTX) Return on Sales [ROS] (2012 - 2025) Analysis & Trends

For FY2025, BioRestorative Therapies posted Return on Sales [ROS] of -4350.05%, down 1468.46 percentage points from FY2024.

  • Return on Sales [ROS] has a five-year change of -775.93 percentage points (FY2020 to FY2025).
  • By year, Return on Sales [ROS] came in at -2881.59% in FY2024 (+7557.89 pp), -10439.49% in FY2023 (+5398.60 pp), -15838.08% in FY2022 (+41352.94 pp) and -57191.03% in FY2021 (-53616.90 pp).
  • Five-year quarterly Return on Sales [ROS] spans a low of -126537.95% in Q4 2022 and a high of -979.02% in Q3 2024.
  • Year over year, Return on Sales [ROS] gained in five of the last eight quarters, with an average year-over-year change of -2646.74 percentage points.
  • The high point for year-over-year Return on Sales [ROS] in five years was Q4 2023 (a gain of 109850.47 percentage points); the low point was Q1 2021 (a drop of 80487.02 percentage points).
  • Per Business Quant data, the three quarters before Q4 2025 came in at -31432.30% (Q3 2025), -1089.77% (Q2 2025) and -19230.14% (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 28.21%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 37.86%
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -3.52%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 32.97%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 20.57%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 34.95%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -133.21%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 28.37%
10 BioRestorative Therapies 976,386.42 -22.96 Mn 17,964.00 -19,516.84%
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -19,516.84%
Sep 30, 2025 -31,432.30%
Jun 30, 2025 -1,089.77%
Mar 31, 2025 -19,230.14%
Dec 31, 2024 -6,212.80%
Sep 30, 2024 -979.02%
Jun 30, 2024 -2,770.83%
Mar 31, 2024 -11,740.72%
Dec 31, 2023 -16,687.47%
Sep 30, 2023 -10,112.19%
Jun 30, 2023 -4,831.86%
Mar 31, 2023 -18,463.57%
Dec 31, 2022 -126,537.95%
Sep 30, 2022 -15,895.52%
Jun 30, 2022 -6,510.03%
Mar 31, 2022 -31,586.21%
Dec 31, 2021 -80,185.34%
Sep 30, 2021 -46,108.59%
Jun 30, 2021 -23,701.75%
Mar 31, 2021 -83,636.98%
API Access

BioRestorative Therapies Return on Sales [ROS] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=BRTX&period=max&api_key=YOUR_API_KEY